Literature DB >> 10529161

Treatment of rheumatoid arthritis with the dopamine agonist quinagolide.

A Eijsbouts, F van den Hoogen, R F Laan, R M Hermus, F C Sweep, L van de Putte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10529161

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  The effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis.

Authors:  M Mobini; Z Kashi; A R Mohammad Pour; E Adibi
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

3.  Construction of a ceRNA Network Related to Rheumatoid Arthritis.

Authors:  Zhanya Huang; Nanzhen Kuang
Journal:  Genes (Basel)       Date:  2022-04-06       Impact factor: 4.141

Review 4.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

Review 5.  Dopaminergic Agents in Rheumatoid Arthritis.

Authors:  Silvia Capellino
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.